Instil Bio (TIL) Other Operating Expenses (2024 - 2026)
Instil Bio (TIL) posted quarterly Other Operating Expenses of $1.6 million for Q1 2026, down 83.8% quarter-over-quarter from $10.0 million in Q2 2025.
Instil Bio (TIL) Other Operating Expenses (2024 - 2026) Analysis & Trends
Instil Bio's Other Operating Expenses history runs 3 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $11.6 million (up 16.2% YoY), while the FY2025 annual figure was $10.0 million, changed 0.0% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $1.6 million, down from $10.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $10.0 million in Q3 2024, with the low at $1.6 million in Q1 2026.
- The 3-year median for Other Operating Expenses is $10.0 million (2024), against an average of $7.2 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.62 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |